WASHINGTON, DC — Michael D. Hogue, PharmD, FAPhA, FNAP, FFIP, executive vice president and CEO of APhA, commended the Federal Trade Commission’s (FTC) action today against alleged practices by large vertically integrated pharmacy benefit managers (PBMs) “for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs, impaired patients’ access to lower list price products, and shifted the cost of high insulin list prices to vulnerable patients.”

Today, the American Pharmacists Association (APhA) and the American Society of Health-System Pharmacists (ASHP) jointly recognize September 20 as Pharmacy Workforce Suicide Awareness Day. Established in 2023 as part of September’s Suicide Prevention Month, this day is dedicated to raising awareness and fostering discussion about a critically important yet often stigmatized topic that disproportionately affects healthcare professionals, including the pharmacy workforce. 

WASHINGTON, DC — Today, the American Pharmacists Association (APhA) and the Contraceptive Access Initiative (CAI) released a new report, “Accessible Consumer Choices: Shaping the Future of Contraceptive Care at Pharmacies.” The report identifies key barriers and proposes solutions for creating more accessible pathways for consumers to obtain contraception.

WASHINGTON, DC—The American Pharmacists Association (APhA) has selected four recipients of its 2024 Impacting Immunization Implementation Through Quality Improvement Grant, recognizing pharmacy residents who have developed continuous quality improvement (CQI) projects designed to positively impact immunization processes at pharmacy practice sites across the country.

WASHINGTON, DC— Today the American Pharmacists Association (APhA) and the National Alliance of State Pharmacy Associations (NASPA) released the tenth installment of the Pharmacy Workplace and Well-being Reporting (PWWR) trends and learnings report series.